Molecular mechanisms and treatment strategies for Dupuytren’s disease
David B O’Gorman1,2,3,4, Linda Vi1,2,5, Bing Siang Gan1,2,3,5,61Cell and Molecular Biology Laboratory, 2The Hand and Upper Limb Centre, St. Joseph’s Health Care London, Schulich School of Medicine and Dentistry, 3Departments of Surgery, 4Biochemistry, 5Physiology and Phar...
Main Authors: | David B O’Gorman, Linda Vi, Bing Siang Gan |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-08-01
|
Series: | Therapeutics and Clinical Risk Management |
Online Access: | http://www.dovepress.com/molecular-mechanisms-and-treatment-strategies-for-dupuytrenrsquos-dise-a5142 |
Similar Items
-
Update on the management of Dupuytren’s contracture
by: Linda Vi, et al.
Published: (2010-08-01) -
Type-1 Collagen differentially alters β-catenin accumulation in primary Dupuytren's Disease cord and adjacent palmar fascia cells
by: Gan Bing, et al.
Published: (2009-06-01) -
Ceruloplasmin and iron in Alzheimer’s disease and Parkinson’s disease: a synopsis of recent studies
by: Kristinsson J, et al.
Published: (2012-11-01) -
Dupuytren's disease
by: Rames Mattar Junior
Published: (2008-03-01) -
Dupuytren’s disease
by: Richard Trèves
Published: (2011-09-01)